Alex Harding
Corporate Officer/Principal at CRISPR THERAPEUTICS AG
Alex Harding active positions
Companies | Position | Start | End |
---|---|---|---|
CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 2023-01-04 | - |
Career history of Alex Harding
Former positions of Alex Harding
Companies | Position | Start | End |
---|---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2017-12-31 | 2019-12-30 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Training of Alex Harding
Harvard Business School | Masters Business Admin |
Yale University | Undergraduate Degree |
The Johns Hopkins University | Doctorate Degree |
Statistics
International
United States | 6 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 2 |
Private Equity Analyst | 1 |
Masters Business Admin | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Private companies | 2 |
---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Alex Harding
- Experience